2024-06-03 10:15:02 ET
2024-06-03 10:15:02 ET
Market Wire News is a media platform, the information on this page was provided by KlickAnalytics via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Harrow Health Inc. Company Name:
HROW Stock Symbol:
Market:
Topline Readout Expected in Q4 2024 Melt Pharmaceuticals, Inc. (“Melt”), a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced that the first patient has been dosed in its Phase 3 program evaluating the safety and effi...
Data Demonstrates Sustained Safety and Efficacy in Treating Signs and Symptoms of Dry Eye Disease Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, is pleased to announce results from its ESSENCE‑2 open-label extension (OLE) clinical study for VEVYE&...
2024-06-03 10:15:02 ET Lake Street analyst issues BUY recommendation for HROW on June 3, 2024 08:56AM ET. The previous analyst recommendation was Buy. HROW was trading at $18.125 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ana...